clinicaltrialsarena12 小时
Annovis begins treatment of subjects in Alzheimer’s trial
Annovis Bio has commenced the treatment of subjects in a Phase III clinical trial of buntanetap in treating early Alzheimer's ...
clinicaltrialsarena17 小时
Qlaris Bio’s QLS 111 therapy shows positive outcomes in Phase II trials
Qlaris Bio has reported positive topline outcomes from two Phase II US trials of QLS 111 in individuals with POAG and OHT.